Tirzepatide, a dual GIP/GLP1-receptor co-agonist preserves cardiac function and improves survival in angiotensin II-induced heart failure model in mice: comparison to liraglutide.
Saved in:
| Title: | Tirzepatide, a dual GIP/GLP1-receptor co-agonist preserves cardiac function and improves survival in angiotensin II-induced heart failure model in mice: comparison to liraglutide. |
|---|---|
| Authors: | Hegedűs, Zsombor I.1,2,3,4 (AUTHOR), Jakab, Márk E.1,2,3,4 (AUTHOR), Gergely, Tamás G.1,2,3,4 (AUTHOR), Sayour, Nabil V.1,2,3,4 (AUTHOR), Kovács, Andrea1,2,3,4 (AUTHOR), Antal, Sára1,2 (AUTHOR), Kovács, Tamás1,2,3,4 (AUTHOR), Ferdinandy, Péter1,2,5 (AUTHOR), Varga, Zoltán V.1,2,3,4 (AUTHOR), Tóth, Viktória E.1,2,3,4 (AUTHOR) toth.viktoria@semmelweis.hu |
| Source: | Cardiovascular Diabetology. 6/14/2025, Vol. 24 Issue 1, p1-16. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14752840 |
|---|---|
| DOI: | 10.1186/s12933-025-02806-5 |
